Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998
Cancers (Basel). 2024 Oct 9;16(19):3427.
doi: 10.3390/cancers16193427.
1 Children and Young People's Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton SM2 5PT, UK.
2 Children's Hospital for Wales, Cardiff CF14 4XW, UK.
3 Department of Paediatric Oncology, Gustave Roussy, 75015 Paris, France.
4 Department of Paediatric Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.
5 Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
6 The Institute of Cancer Research, London SW7 3RP, UK.
7 Department of Radiology and Nuclear Medicine, University of Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.
8 Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
9 Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.
10 Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
11 Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.
12 University Hospital Copenhagen, DK-2200 Copenhagen, Denmark.
13 Department of Paediatric Oncology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.
14 Department of Women and Children's Health, University of Padova, 35122 Padua, Italy.
15 Alice's Arc Charity, London EC1V 1AW, UK.
16 KickCancer Foundation, 1000 Brussels, Belgium.
17 Vivo Biobank, Translational & Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.